This article is more than 5 years old. Information may no longer be current.

Life Spine announces FDA clearance of Long Bow interbody system

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Life Spine announced recently that the U.S. Food and Drug Administration has granted 510(k) marketing clearance to the Long Bow Expandable Lateral Interbody System.

The system is the first interbody system on the market that expands laterally in situ specifically for a direct lateral approach, according to a company press release.

Using the system, surgeons can decrease the amount of retraction by up to 45% compared with use of current lateral systems, according to the release. The system is also designed to help minimize tissue retraction and potential nerve damage that can occur with the lateral-access approach.

Long Bow is scheduled for a full product release in the first quarter of 2015 but will also see a limited release at the end of 2014, according to the press release.

Reference: www.lifespine.com